Chile Neurology Devices Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Chile's neurology devices market is concentrated in Santiago and major urban centers, where the country's advanced hospital infrastructure, relative to much of Latin America, supports greater adoption of specialized neurotechnology. Publicly available sizing data for this market is limited, with most estimates derived from private market intelligence firms rather than Chile's official government statistical agencies. The market covers neurovascular, neurostimulation, and neurosurgery devices, serving both public hospitals under the FONASA national health scheme and the private ISAPRES insurance network.

• •Market size estimated at USD 43.80 million in 2025, making it one of the smaller but more developed neurology device markets in South America
• •Reliable public data is scarce; market estimates are largely sourced from private industry research using customs import data
• •Products span neurovascular intervention tools, deep brain stimulation systems, and intracranial pressure monitoring devices

Chile's aging population is a core driver, as the proportion of residents over 65 continues to rise, increasing demand for devices used in stroke treatment, Parkinson's disease management, and neurodegenerative conditions. Expanding access to neurosurgical and interventional neurology services outside Santiago is gradually broadening the addressable market beyond the capital. Additionally, Chile's relatively high per capita GDP and stable regulatory environment make it an early adopter for new neurotechnology compared to neighboring countries.

• •Rising prevalence of cerebrovascular disease, Chile has one of the highest stroke mortality rates in the Americas per PAHO data
• •Growing adoption of minimally invasive neurosurgical techniques requiring specialized catheter and coil devices
• •Government health spending on specialized medical equipment continues to increase through FONASA and public hospital tenders

Within Chile, neurovascular devices represent a significant portion of the market, consistent with the global neurovascular segment's rapid 9.3% CAGR. Neurostimulation devices, valued at USD 423.9 million across Latin America in 2025, are also relevant to Chile given the country's relatively high rates of private-pay elective procedures such as deep brain stimulation. Chile sits within a broader Latin American context where the overall neurology devices market is forecast to reach USD 855.6 million by 2030, growing faster than Chile's individual market pace.

• •Neurovascular interventions (stents, coils, flow diverters) are among the highest-growth device categories in the Chilean market
• •Neurostimulation devices for epilepsy and movement disorders represent an emerging segment driven by private healthcare demand
• •Chile's individual market CAGR trails the broader Latin American average, reflecting its more developed (and slower-growing) healthcare penetration

What are the recent trends and outlook?

Over the coming decade, the Chile neurology devices market is expected to sustain modest but steady growth, with forecasts ranging from approximately 2.8% to 4.2% CAGR depending on the methodology used. Advances in minimally invasive neurovascular intervention, robotic-assisted neurosurgery, and digital health integration are gradually influencing product preferences among Chilean clinicians. However, budget constraints in the public healthcare system and currency fluctuations will likely keep growth below the Latin American regional average.

• •Long-term outlook projects the market reaching roughly USD 55-65 million by 2030, maintaining its position as a niche but stable segment
• •Adoption of flow diversion and stent-retriever technologies for acute ischemic stroke is expected to accelerate neurovascular device demand
• •Data-driven predictive care models, aligned with global neurology trends, may drive future investment in diagnostic and monitoring devices